Ronald A. DePinho 13D and 13G filings for Cara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 5:01 pm Sale | 2025-09-30 | 13G | CARA THERAPEUTICS INC CARA | Ronald A. DePinho | 626,190 6.700% | -154,800 (-19.82%) | Filing |
| 2025-06-02 09:04 am Purchase | 2025-04-15 | 13G | CARA THERAPEUTICS INC CARA | Ronald A. DePinho | 780,990 8.300% | 780,990 (New Position) | Filing |